Table 2.
Scales | |||||
---|---|---|---|---|---|
PCL-M | Total RPQ | RPQ-3 | RPQ-13 | ||
Serum TNFα | Pearson correlation | −0.103 | 0.209 | 0.137 | 0.205 |
Sig. (2-tailed) | 0.666 | 0.390 | 0.575 | 0.400 | |
N | 20 | 19 | 19 | 19 | |
Serum IL-6 | Pearson correlation | −0.015 | 0.085 | 0.184 | 0.059 |
Sig. (2-tailed) | 0.949 | 0.728 | 0.451 | 0.809 | |
N | 20 | 19 | 19 | 19 | |
Serum IL-10 | Pearson correlation | −0.144 | −0.403 | −0.115 | −0.423 |
Sig. (2-tailed) | 0.556 | 0.097 | 0.649 | 0.080 | |
N | 19 | 18 | 18 | 18 | |
Serum IL-6/IL-10 | Pearson correlation | 0.140 | 0.526* | 0.339 | 0.515* |
Sig. (2-tailed) | 0.566 | 0.025 | 0.168 | 0.029 | |
N | 19 | 18 | 18 | 18 | |
Neuronal-derived EV TNFα | Pearson correlation | 0.097 | −0.213 | −0.126 | −0.216 |
Sig. (2-tailed) | 0.720 | 0.446 | 0.655 | 0.439 | |
N | 16 | 15 | 15 | 15 | |
Neuronal-derived EV IL-6 | Pearson correlation | 0.135 | 0.227 | −0.010 | 0.249 |
Sig. (2-tailed) | 0.593 | 0.382 | 0.968 | 0.335 | |
N | 18 | 17 | 17 | 17 | |
Neuronal-derived EV IL-10 | Pearson correlation | −0.149 | −0.478 | −0.378 | −0.461 |
Sig. (2-tailed) | 0.556 | 0.052 | 0.134 | 0.063 | |
N | 18 | 17 | 17 | 17 | |
Neuronal-derived EV IL-6/IL-10 | Pearson correlation | 0.205 | 0.585* | 0.346 | 0.580* |
Sig. (2-tailed) | 0.445 | 0.022 | 0.207 | 0.023 | |
N | 16 | 15 | 15 | 15 |
indicates significant correlation (2-tailed).